Navigation Links
Eyeforpharma's Marketing Summit is shaping up to be the biggest event of its kind ever
Date:9/9/2008

Pharma’s Successful changing marketing approaches

LONDON, September 8, 2008 / b3c newswire /  – The looming recession certainly does not seem to have hit the European pharmaceutical industry yet.  With more than twice as many registered attendees as in past years, eyeforpharma’s upcoming Marketing Summit Europe, October 20-21 in Zurich is shaping up to be the biggest event of its kind ever.

Companies obviously know that thriving in today’s market means staying on top of their game and perhaps nowhere is that more important than in the rapidly changing pharmaceutical space.

Ultimately, the most successful pharmaceutical companies,  says Michael Zaiac, assistant vice president medical affairs EMEA at Wyeth, will be those who invest heavily in understanding the industry’s new stakeholders – especially patients, payers and policy makers – and employ an early feedback loop into their clinical discovery and development programs to steer products toward better meeting the needs of these stakeholders.

Companies that are quick on the uptake and willing to invest in the necessary skill sets to connect with these new customers, by either acquiring them from outside or training existing employees, Zaiac says, can positively differentiate themselves from their competitors and bring products to market more successfully.

Baba Awopetu, Manager of Brand Strategy EMEA at Stryker, says more stakeholders mean a more complex and complicated environment, and pharma marketers must consider where the power base lies and how much influence each group has given a company’s specific circumstances. Companies may find they have primary and secondary stakeholders, depending on the therapy area, product lifecycle or other factors, he suggests.

With a wider audience, pharmas will nee
'/>"/>

b3c newswire

Page: 1 2

Related biology technology :

1. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
2. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
3. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
4. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
5. Phlo Affiliate Hires Chief Marketing Officer With Extensive Global Experience
6. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
7. Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance
8. Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug
9. Phlo Affiliate Names Director Of Marketing
10. Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market
11. Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014  Pfenex Inc. (NYSE MKT: PFNX), ... of high-value and difficult to manufacture proteins including ... reported financial results for the second quarter ended ... completion of our initial public offering, we have ... product candidates, derived from our proprietary protein expression ...
(Date:8/29/2014)... on electrons, but one of the most promising technologies ... based on light (photons) instead of electrons. First, it ... of single photons and control their direction. Researchers around ... achieve this control, but now scientists at the Niels ... of photons emitted one at a time and in ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 The ... $5.6 billion in 2019. It is expected to ... to 2019, and was valued at $1.8 billion ... by Transparency Market Research. , For more information ... http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research report, titled “Companion ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to a ... Market” the global orthobiologics market was valued at USD 3,754.6 ... worth USD 5,519.9million in 2019at a CAGR of 5.9% from ... 50 years and above is afflicted by bone and joint ... the year 2020. This has and will continue to increase ...
Breaking Biology Technology:Pfenex Reports Second Quarter 2014 Results and Provides Business Update 2Pfenex Reports Second Quarter 2014 Results and Provides Business Update 3Pfenex Reports Second Quarter 2014 Results and Provides Business Update 4Pfenex Reports Second Quarter 2014 Results and Provides Business Update 5Pfenex Reports Second Quarter 2014 Results and Provides Business Update 6Pfenex Reports Second Quarter 2014 Results and Provides Business Update 7Pfenex Reports Second Quarter 2014 Results and Provides Business Update 8Breakthrough in light sources for new quantum technology 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3
... Amarin Corporation plc,(NASDAQ: AMRN ) ("Amarin" or ... of Amarin, will present at the Acumen,BioFin Rodman & ... 12 noon Eastern time. The conference will be held ... New York. The presentation will be simultaneously webcast ...
... NeurogesX, Inc.,(Nasdaq: NGSX ), a biopharmaceutical company ... that it is scheduled to present,on Monday, November ... Annual,Healthcare Conference and on Tuesday, November 6, 2007 ... Healthcare Conference. Anthony DiTonno,President and Chief Executive Officer, ...
... October 31 Revotar,Biopharmaceuticals AG., today announced first ... IIa pilot study in 14 patients with,stable COPD ... mg of Bimosiamose,twice a day. The study was ... Prof. Witt and the Respiratory Institute Wiesbaden, Dr.,Beeh. ...
Cached Biology Technology:Amarin Corporation to Present at Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference 2Amarin Corporation to Present at Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference 3NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 3Revotar Reports First Positive Clinical Results From Phase IIa Study in COPD 2
(Date:8/29/2014)... Researchers at UC Davis have made some surprising ... infection. Studying simian immunodeficiency virus (SIV), the team ... Paneth cells are early responders to viral invasion ... producing a cytokine called interleukin-1 beta (IL-1β). ... IL-1β causes breakdown of the gut epithelium that ...
(Date:8/29/2014)... (Aug. 29, 2014) Scientists at the Barshop Institute ... of Medicine at the UT Health Science Center at ... the tissues of the longest-lived rodent, the naked mole ... the cells of naked mole rats protects and alters ... damaged and obsolete proteins. , The factor also protects ...
(Date:8/29/2014)... been known about what genetic changes transform wild animals ... of whom is a University of Montana assistant professor, ... the development of the brain and the nervous system ... published Aug. 28 in Science and gives ... http://www.sciencemag.org/ ., The domestication of animals and plants, ...
Breaking Biology News(10 mins):The early cost of HIV 2Factor in naked mole rat's cells enhances protein integrity 2New research reveals how wild rabbits were genetically transformed into tame rabbits 2New research reveals how wild rabbits were genetically transformed into tame rabbits 3
... too short, then you,re not alone. A team of scientists from Texas ... long life and they made important discoveries that bring longer life spans ... of The FASEB Journal ( http://www.fasebj.org ), describes how scientists ... the process discovered a new metabolic state correlating with long life. ...
... of two studies published in the current issue of ... cerebral ischemia and ischemic stroke in rats may significantly ... found that administering bone marrow stromal stem cells (MSC) ... which coincided with activation of microglia and new blood ...
... This release is available in German . , ... reliable testing of HIV inhibitors. This system was developed under ... Virology. At the heart of the system are cultured human ... that signal HIV infection by producing a red fluorescent protein. ...
Cached Biology News:Longevity breakthrough: The metabolic state of mitochondria controls life span 2Stroke research takes 2 steps forward 2Stroke research takes 2 steps forward 3A powerful new technology to identify HIV inhibitors 2
Request Info...
...
...
... are available in two product models - the ... models is that the 6000AT+ includes a membrane ... aerosol for improved detection limits and reduced oxides. ... range of elements by 10-40 times. Note that ...
Biology Products: